The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
Publications
The double-edged sword of daptomycin: a case of daptomycin-induced eosinophilic pneumonia.
Oxford medical case reports. 2026;2026(8):omag146
Daptomycin and acute lung injury: recognising drug-induced eosinophilic pneumonia.
BMJ case reports. 2025;18(7)
A Diagnostic Dilemma: Daptomycin-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome and Eosinophilic Pneumonia With Concurrent COVID-19.
Cureus. 2025;17(1):e77736
Eosinophilic Pneumonia Induced by Daptomycin.
Cureus. 2024;16(2):e55095
Di Lorenzo A, Rindi LV, Campogiani L, Imeneo A, Alessio G, Pace PG, Lodi A, Rossi B, Crea AMA, Vitale P, Kontogiannis D, Malagnino V, Andreoni M, Iannetta M, Sarmati L
Daptomycin-Induced Eosinophilic Pneumonia: A Case Report and Systematic Review.
Chemotherapy. 2024;69(2):85-99
Daptomycin-Induced Pulmonary Toxicity: A Case Series.
Cureus. 2023;15(5):e39613
Seventeen Cases of Daptomycin-Induced Eosinophilic Pneumonia in a Cohort of Patients Treated for Bone and Joint Infections: Proposal for a New Algorithm.
Open forum infectious diseases. 2022;9(11):ofac577
Daptomycin-Induced Eosinophilic Pneumonia Mimicking Multifocal Pneumonia.
Cureus. 2022;14(10):e30521
Eosinophilic Syndromes Associated With Daptomycin Use: Re-exposure Hypersensitivity Pneumonitis and Prior Peripheral Eosinophilia.
Open forum infectious diseases. 2022;9(4):ofac065
Acute Eosinophilic Pneumonia Secondary to Daptomycin.
Cureus. 2021;13(11):e19403
Multifocal Pneumonia Amidst the Global COVID-19 Pandemic: A Case of Daptomycin-Induced Eosinophilic Pneumonia.
Cureus. 2021;13(6):e16002
Eosinophilic pneumonia: a case of daptomycin induced lung injury.
Journal of community hospital internal medicine perspectives. 2021;11(2):280-285
Daptomycin-induced eosinophilic pneumonia: Are there any risk factors?
Infectious diseases now. 2021;51(7):618-621
Daptomycin-Induced Acute Eosinophilic Pneumonia.
Cureus. 2021;13(2):e13509
Unexpected Outcome of Daptomycin-induced Eosinophilic Pneumonia: Rarity Within a Rarity.
Cureus. 2019;11(12):e6271
Daptomycin associated eosinophilic pneumonia: case report and differential diagnoses.
Journal of community hospital internal medicine perspectives. 2018;8(3):152-155
Drug-induced eosinophilic pneumonia: A review of 196 case reports.
Medicine. 2018;97(4):e9688
Higashi Y, Nakamura S, Tsuji Y, Ogami C, Matsumoto K, Kawago K, Tokui K, Hayashi R, Sakamaki I, Yamamoto Y
Daptomycin-induced Eosinophilic Pneumonia and a Review of the Published Literature.
Internal medicine (Tokyo, Japan). 2018;57(2):253-258
Hirai J, Hagihara M, Haranaga S, Kinjo T, Hashioka H, Kato H, Sakanashi D, Yamagishi Y, Mikamo H, Fujita J
Eosinophilic pneumonia caused by daptomycin: Six cases from two institutions and a review of the literature.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2017;23(4):245-249
Daptomycin-induced eosinophilic pneumonia - a systematic review.
Antimicrobial resistance and infection control. 2016;5:55
Durante-Mangoni E, Andini R, Parrella A, Mattucci I, Cavezza G, Senese A, Trojaniello C, Caprioli R, Diana MV, Utili R
Safety of treatment with high-dose daptomycin in 102 patients with infective endocarditis.
International journal of antimicrobial agents. 2016;48(1):61-68
[Acute eosinophilic pneumonia secondary to daptomycin].
Enfermedades infecciosas y microbiologia clinica. 2016;34(6):390-1
Dyspnea on daptomycin: eosinophilic pneumonia.
Rhode Island medical journal (2013). 2015;98(6):41-3
Daptomycin-associated eosinophilic pneumonia in two patients with prosthetic joint infection.
Surgical infections. 2014;15(6):834-7
Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports.
Drug safety. 2012;35(6):447-57
A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia.
Infection. 2011;39(6):583-5
Eosinophilic pneumonia associated with daptomycin: a case report and a review of the literature.
Journal of medical case reports. 2011;5:13
Eosinophilic pneumonia induced by daptomycin.
The Journal of infection. 2007;54(4):e211-3